To determine the potential involvement of gut microbiota in CFP-mediated amelioration of diabetes and its complications, 16S rRNA sequencing of fecal microbiota was performed after 4, 8, and 12 weeks of treatment. This evidence concerns the gene CFP and diabetes mellitus.